Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
Leukemia & Lymphoma
|
October 23, 2015
Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remission
Gabriel N Mannis, Thomas G Martin, Lloyd E Damon, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 22, 2021
Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial
Swetha Kambhampati, Bita Fakhri, Weiyun Z Ai, et al.
Haematologica
|
August 30, 2023
Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: long-term efficacy and safety from the phase II LOTIS-2 study
Paolo F Caimi, Weiyun Z Ai, Juan Pablo Alderuccio, et al.
Current Medicinal Chemistry
|
September 12, 2012
Hepatocyte-targeted delivery using ph-sensitive liposomes loaded with lactosylnorcantharidin phospholipid complex: preparation, characterization, and therapeutic evaluation in vivo and in vitro
Z Qiao-ling, Z Yi, G Min, et al.
Haematologica
|
July 13, 2023
Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter study
Swaminathan P Iyer, Auris Huen, Weiyun Z Ai, et al.
Zhonghua Yi Xue Za Zhi
|
November 15, 2021
[Current status of hyperkalemia in dialysis patients in China]
N Y Huang, Y Y Liu, J W Yu, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 18, 2015
A phase I study of targeted, dose-escalated intravenous busulfan in combination with etoposide as myeloablative therapy for autologous stem cell transplantation in acute myeloid leukemia
Gabriel N Mannis, Charalambos Andreadis, Aaron C Logan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 19, 2023
PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial
Juan Pablo Alderuccio, Isildinha M Reis, Mehdi Hamadani, et al.
Bone Marrow Transplantation
|
September 23, 2014
Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis
G N Mannis, A C Logan, A D Leavitt, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 10, 2012
Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
Leukemia & Lymphoma
|
October 23, 2015
Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remission
Gabriel N Mannis, Thomas G Martin, Lloyd E Damon, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 22, 2021
Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial
Swetha Kambhampati, Bita Fakhri, Weiyun Z Ai, et al.
Haematologica
|
August 30, 2023
Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: long-term efficacy and safety from the phase II LOTIS-2 study
Paolo F Caimi, Weiyun Z Ai, Juan Pablo Alderuccio, et al.
Current Medicinal Chemistry
|
September 12, 2012
Hepatocyte-targeted delivery using ph-sensitive liposomes loaded with lactosylnorcantharidin phospholipid complex: preparation, characterization, and therapeutic evaluation in vivo and in vitro
Z Qiao-ling, Z Yi, G Min, et al.
Haematologica
|
July 13, 2023
Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter study
Swaminathan P Iyer, Auris Huen, Weiyun Z Ai, et al.
Zhonghua Yi Xue Za Zhi
|
November 15, 2021
[Current status of hyperkalemia in dialysis patients in China]
N Y Huang, Y Y Liu, J W Yu, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 18, 2015
A phase I study of targeted, dose-escalated intravenous busulfan in combination with etoposide as myeloablative therapy for autologous stem cell transplantation in acute myeloid leukemia
Gabriel N Mannis, Charalambos Andreadis, Aaron C Logan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 19, 2023
PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial
Juan Pablo Alderuccio, Isildinha M Reis, Mehdi Hamadani, et al.
Bone Marrow Transplantation
|
September 23, 2014
Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis
G N Mannis, A C Logan, A D Leavitt, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 10, 2012
Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Page
of 7